Vistabex (Botulinum Toxin Type A) - Study Drug

botulinum toxin type A · Croma-Pharma GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vistabex (Botulinum Toxin Type A) - Study Drug, covering 2025-03-18 to 2025-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines [Phase 2]